Anxiolytics and sedative-hypnotics: Nursing pharmacology

00:00 / 00:00

Notes

ANXIOLYTICS AND SEDATIVE-HYPNOTICS, PART 1
DRUG NAME
Short-acting (-azolam):
alprazolam (Xanax)
midazolam (Nayzilam)

Intermediate-acting 
(-azepam):
lorazepam (Ativan)
clonazepam (KlonoPIN)

Long-acting (-azepam):
diazepam (Valium)
butabarbital,

pentobarbital 
(Nembutal sodium),

phenobarbital
CLASS
Benzodiazepines
Barbiturates
MECHANISM OF ACTION
  1. Bind to GABAA receptors
  2. ↑ frequency of Cl- channel opening; ↑ Cl-  influx
  3. Membrane hyperpolarization;
    ↓ neuronal excitability
  1. Bind to GABAA receptors
  2. ↑ duration of Cl- channel opening; ↑ Cl-  influx
  3. Membrane hyperpolarization; ↓ neuronal excitability
INDICATIONS
  • Anxiety
  • Preoperative sedation
  • Anesthesia induction
  • Sedation for mechanical ventilation
  • Alcohol withdrawal syndrome
  • Status epilepticus
  • Anxiety
  • Preoperative sedation
  • Convulsions
  • Induced coma


ROUTE(S) OF ADMINISTRATION
PO, IV, IM, SC, SL, PR
PO, IV, IM
SIDE EFFECTS
  • Headache, sedation, dizziness
  • Blurred vision, dry mouth
  • Urinary incontinence, constipation
  • Leukopenia
  • Paradoxical stimulation
  • Tolerance, dependence, and withdrawal symptoms
  • Headache, somnolence, confusion
  • CNS depression, hallucinations, vertigo
  • Nausea, vomiting, diarrhea
  • Asthenia, ataxia
  • Paradoxical stimulation
  • Tolerance, dependence, and withdrawal symptoms
  • Stevens-Johnson syndrome
CONTRAINDICATIONS AND CAUTIONS
  • Myasthenia gravis
  • Concomitant use with other CNS depressants
  • Acute narrow-angle glaucoma
  • Pregnancy, breastfeeding
  • Concomitant use with other CNS depressants
  • Hypotension, laryngospasm, bronchospasm
NURSING CONSIDERATIONS
Assessment and monitoring
  • Vital signs - include orthostatic hypotension assessment
  • Weight
  • LOC
  • Laboratory values: CBC, hepatic, renal, cardiac function
  • Current medications
  • Side effects - report to provider and intervene if necessary
  • Administer IV dose slowly

Client education

  • Teach the client to monitor for and report side effects
  • Avoid hazardous activities like driving until response is known
  • Keep clients who receive parenteral doses in bed for at least three hours to ensure safety
  • Provide safety measures like raising side-rails and ensuring adequate lighting
  • Make position changes slowly to reduce effects of orthostatic hypotension
  • Avoid grapefruit juice if taking alprazolam or midazolam
Assessment and monitoring
  • Vital signs - include orthostatic hypotension assessment
  • Weight
  • LOC
  • Laboratory values: CBC, hepatic, renal, cardiac function
  • Current medications
  • Side effects - report to provider and intervene if necessary
  • Have resuscitative equipment nearby
  • Phenobarbital for long-term anticonvulsant therapy - monitor serum folate levels
  • Administer IV dose slowly

Client education
  • Teach the client to monitor for and report side effects
  • Avoid hazardous activities like driving until response is known
  • Provide safety measures like raising side-rails and ensuring adequate lighting
  • Can reduce the efficacy of oral contraceptives
  • Make position changes slowly to reduce effects of orthostatic hypotension
  • Promptly report flu-like symptoms or a rash which could indicate Stevens-Johnson syndrome
ANXIOLYTICS AND SEDATIVE-HYPNOTICS, PART 2
DRUG NAME
zolpidem (Ambien),
zaleplon,
eszopiclone (Lunesta)

buspirone
CLASS
Hypnotic;
Non-benzodiazepines
Miscellaneous anxiolytics
MECHANISM OF ACTION
  1. Bind to GABAA receptors
  2. ↑ frequency of Cl- channel opening; ↑ Cl-  influx
  3. Membrane hyperpolarization;
    ↓ neuronal excitability
  1. Bind to and activate 5-HT1 receptors
  2. Bind to and block DA2 receptors
INDICATIONS
Insomnia
Anxiety
ROUTE(S) OF ADMINISTRATION
PO
SIDE EFFECTS
  • Headache
  • Hot flashes
  • Drowsiness
  • Anxiety
  • Nausea, vomiting
  • Ataxia
  • Erectile dysfunction
  • Tolerance, dependence, and withdrawal symptoms
  • Headache, sedation, dry mouth
CONTRAINDICATIONS AND CAUTIONS
  • Concomitant use with other CNS depressants
  • Hepatic / renal impairment
NURSING CONSIDERATIONS
Assessment and monitoring
  • Vital signs
  • Weight
  • LOC
  • Laboratory values: CBC, hepatic, renal, cardiac function
  • Current medications
  • Side effects - report to provider and intervene if necessary

Client education
  • Teach the client to monitor for and report side effects
  • Avoid hazardous activities like driving until response is known
  • Provide safety measures like raising side-rails and ensuring adequate lighting 
  • Take only if able to get a full night’s sleep (7–8 hrs)
  • Dangerous sleep behaviors like sleep-walking and sleep-driving may occur
Assessment and monitoring
  • Vital signs
  • Weight
  • LOC
  • Laboratory values: CBC, hepatic, renal, cardiac function
  • Current medications
  • Side effects - report to provider and intervene if necessary

Client education
  • Teach the client to monitor for and report side effects
  • Avoid hazardous activities like driving until response is known
  • Notify provider if chronic abnormal movements like dystonia, motor restlessness, or involuntary movement of facial or cervical muscles occurs
  • Avoid large amounts of grapefruit


Transcript

Watch video only

Anxiolytics and sedative-hypnotics are medications that act as central nervous system depressants that reduce tension and induce calm or sleep, and are primarily used to relieve anxiety, as well as insomnia.

It’s important to note that the preferred medications for the long-term management of anxiety are typically selective serotonin reuptake inhibitors, or SSRIs for short, due to their low abuse potential and dependence.

But, medications that can be used for the short-term management include benzodiazepines, barbiturates, and miscellaneous anxiolytics.

First, let’s start with benzodiazepines. These medications are usually taken orally, but some of them can also be administered intravenously, intramuscularly, subcutaneously, sublingually, or even rectally.

Now, based on the overall duration of action, benzodiazepines can be subdivided into three main groups.

The first group includes short-acting benzodiazepines, which typically end in -azolam, such as alprazolam and midazolam; the second group covers intermediate-acting benzodiazepines that end in -azepam, like lorazepam and clonazepam; and finally, the third group includes long-acting benzodiazepines that also end in -azepam, such as diazepam.

In addition to treating anxiety and insomnia, benzodiazepines are also indicated for treatment for status epilepticus, where a person has ongoing or multiple seizures for over 5 minutes.

Fuentes

  1. "Mosby's 2021 Nursing Drug Reference" Mosby (2021)
  2. "Pharmacology: A Patient-Centered Nursing Process Approach (8e)" Elsevier Health Sciences (2014)
  3. "Focus on Nursing Pharmacology" LWW (2019)
  4. "Saunders Comprehensive Review for the NCLEX-RN Examination" Saunders (2019)
Elsevier

Copyright © 2024 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Cookies are used by this site.

USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.

RELX